Regulations are made by the government to protect public health by ensuring the safety and efficacy of medicines, vaccines, and medical devices. Based on regional and economic constraints, the regulatory bodies around the globe differ in their guidelines, making it challenging even for regulatory affairs professionals to navigate. To aid in the understanding of these variations, BCS recently organised a three-part webinar-based workshop series on regulatory affairs, given by experts in different domains of regulation in Asia, Europe, and America.
As part of COVID-19 webinar series, Biotech Connection Singapore (BCS) hosted speakers from academic and industry settings to discuss advances in the research community under the new ‘norm’, as well as the research efforts undertaken in facilitating basic and translational research in the fight against SARS-COV-2. The panel included:
Dr. Ooi Eng Eong, Professor and Deputy Director of the Emerging Infectious Diseases Programme at Duke-NUS Medical School
Mr. Rajeev Nair, Senior VP and Head of APAC Research Solutions, Life Science, Merck
Mr. Mark Dupal, APAC Senior Sales Director of Twist Bioscience
The essential stay home conversations is a series of webinars curated by BCS to explore how the biomedical community is responding to the COVID-19 pandemic and how they contribute to bringing this public health crisis under control. Diagnostic testing or detecting the virus in patients is a critical step in determining the public health response and controlling the outbreak. Following the successful launch of our first webinar with Dr. Timothy Barkham (TTSH) about the efforts undertaken at the front lines of COVID-19 testing, we were honoured to have Dr. Sidney Yee, CEO of Diagnostics Development (DxD) Hub at A*STAR, Dr. Lihan Zhou, co-founder and CEO of MiRXES, and Dr. Tan Min Han, CEO and Medical Director of Lucence, to share the exciting journey of developing and manufacturing these crucial diagnostic kits. The webinar was moderated by Dr Mayura Wagle, Vice President of BCS
FThere has been a rapid expansion in AI-based technologies in recent years, including its application in the healthcare space. In this event, we have featured innovators who are using AI-based technologies to improve clinical outcomes, as well as those well-versed in IP protection of such technologies. A huge audience joined us for an evening of short talks and what will be an enlightening discussion on how entrepreneurs, technologists, clinicians and IP experts can come together to drive improvements in healthcare.
Fireside chat with Mr. Ng Choon-Peng, CEO and Co-founder of immunoSCAPE, which provides immune profiling services to drug development companies and research groups focused on developing immunotherapy for cancer, infectious diseases, and autoimmune diseases. The fireside chat was moderated by Ms. Doralyn Chan (Manager, Funding, Entrepreneur First Asia).
IGNite, short for Innovators Gathering Night, is a series of fireside chats with biotech and medtech innovators to find out what ignites their passion to innovate within their fields. It also provides a platform for current and future innovators to meet and network, and ignite conversations leading to collaborative opportunities. The fireside chat is informal and casual, and participation/questions from the audience are greatly encouraged.
Healthcare Connection Night in Singapore, hosted by KPMG and co-organized by Biotech Connection Singapore (BCS) and Singapore Healthcare Drinks (HCD), was an astounding success. The KPMG Clubhouse was packed to the brim with 120+ attendees, ranging from professionals in the pharmaceutical, biotech and medtech industry, to care providers and payers, to entrepreneurs, consultants and investors in the healthcare sector.